2021 Fiscal Year Final Research Report
Development of the new bone creation method with the osteoblastic seat derived from a human pulpal stem cell in the implant treatment
Project/Area Number |
19K19073
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 57040:Regenerative dentistry and dental engineering-related
|
Research Institution | Tokyo Medical University |
Principal Investigator |
MURATA TAKUYA 東京医科大学, 医学部, 兼任助教 (40617718)
|
Project Period (FY) |
2019-04-01 – 2022-03-31
|
Keywords | デンタルインプラント / ヒト歯髄幹細胞 / 骨造成 |
Outline of Final Research Achievements |
In this study, Using the human pulp which is the self-cell which I gathered from an unnecessary withdrawal tooth, differentiation guides a pulpal stem cell to the osteoblasts, and this study manufactures the three-dimensional laminating seat and is to establish the new bone creation system. We divided it into four experimental systems, A, B, C, and D, and made a plan to compare and examine them. In the bone evaluation, it followed that bone destruction advanced in A group, B group, C group, D group, all groups.As a factor, it was thought that the fixation of the osteoblastic laminated seat being difficult, transplant part gingiva wound part protection being difficult, securing of wound region cleanliness state were difficult.
|
Free Research Field |
口腔外科学
|
Academic Significance and Societal Importance of the Research Achievements |
デンタルインプラント植立に際して、歯槽骨欠損患者に頻繁に遭遇し骨量確保に苦慮することがある。この骨量確保に対して、自家骨やバイオマテリアルの開発が急速な進歩を遂げている。しかし、その形状、術中の操作性、安全性に難点を有し、人体への侵襲が未だ大く、より安全で簡便な方法はなく問題が残っている。このような問題を解決する方法として、自己細胞であるヒトES細胞、iPS細胞、骨髄間葉系幹細胞などを用いた再生医療が期待されており、本研究も期待できると考えられた。
|